Stanford University
Showing 291-300 of 374 Results
-
Rita Popat
Associate Professor (Teaching) of Epidemiology
Current Research and Scholarly InterestsMy research interest focuses on the epidemiology of Parkinsons disease and amyotrophic lateral sclerosis, specifically evaluating the genetic and environmental contributions to these neurodegenerative disorders. I am also interested in studying the relation of cognition, estradiol exposure (endogenous and exogenous), and genetic factors.
-
Denise Pope
Senior Lecturer in Education
Current Research and Scholarly InterestsDr. Pope is co-founder of Challenge Success, a research and intervention non-profit affiliated with the GSE that aims to improve student experiences in K-12 schools and champions a broader vision of youth success. Challenge Success is an expanded version of the SOS: Stressed-Out Students project that Dr. Pope founded and directed from 2003-2008. She lectures nationally on parenting techniques and pedagogical strategies to increase student well-being, engagement with learning, and integrity.
-
Richard Popp
Professor of Medicine (Cardiovascular Medicine), Emeritus
Current Research and Scholarly InterestsAcademic-Industrial relations; Ethics of invention.
-
Gallia Porat
Lecturer
BioTwenty years of experience teaching Hebrew to all levels of students. Developed unique teaching techniques that enable students to grasp the fundamentals of Hebrew grammar, enabling them to develop strong comprehension skills and work creatively with the language. Have been teaching beginning and intermediate Hebrew grammar and Biblical Hebrew at the Stanford Language Center since 2004.
-
Edward Porter
Lecturer
BioEdward Porter’s writing has appeared in Glimmer Train, The Gettysburg Review, The Hudson Review, Colorado Review, Catamaran, Barrelhouse, Best New American Voices, and elsewhere. A native of New York City, he earned an MFA from Warren Wilson College and a PhD from the University of Houston, and has been awarded fellowships at the University of Wisconsin-Madison, the MacDowell Colony, and Stanford University, where he was recently a Stegner Fellow. He lives in Oakland.
-
Matthew Porteus
Sutardja Chuk Professor of Definitive and Curative Medicine
BioDr. Porteus was raised in California and was a local graduate of Gunn High School before completing A.B. degree in “History and Science” at Harvard University where he graduated Magna Cum Laude and wrote an thesis entitled “Safe or Dangerous Chimeras: The recombinant DNA controversy as a conflict between differing socially constructed interpretations of recombinant DNA technology.” He then returned to the area and completed his combined MD, PhD at Stanford Medical School with his PhD focused on understanding the molecular basis of mammalian forebrain development with his PhD thesis entitled “Isolation and Characterization of TES-1/DLX-2: A Novel Homeobox Gene Expressed During Mammalian Forebrain Development.” After completion of his dual degree program, he was an intern and resident in Pediatrics at Boston Children’s Hospital and then completed his Pediatric Hematology/Oncology fellowship in the combined Boston Chidlren’s Hospital/Dana Farber Cancer Institute program. For his fellowship and post-doctoral research he worked with Dr. David Baltimore at MIT and CalTech where he began his studies in developing homologous recombination as a strategy to correct disease causing mutations in stem cells as definitive and curative therapy for children with genetic diseases of the blood, particularly sickle cell disease. Following his training with Dr. Baltimore, he took an independent faculty position at UT Southwestern in the Departments of Pediatrics and Biochemistry before again returning to Stanford in 2010 as an Associate Professor. During this time his work has been the first to demonstrate that gene correction could be achieved in human cells at frequencies that were high enough to potentially cure patients and is considered one of the pioneers and founders of the field of genome editing—a field that now encompasses thousands of labs and several new companies throughout the world. His research program continues to focus on developing genome editing by homologous recombination as curative therapy for children with genetic diseases but also has interests in the clonal dynamics of heterogeneous populations and the use of genome editing to better understand diseases that affect children including infant leukemias and genetic diseases that affect the muscle. Clinically, Dr. Porteus attends at the Lucille Packard Children’s Hospital where he takes care of pediatric patients undergoing hematopoietic stem cell transplantation.
